1. Home
  2. SYRE vs KFRC Comparison

SYRE vs KFRC Comparison

Compare SYRE & KFRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • KFRC
  • Stock Information
  • Founded
  • SYRE 2013
  • KFRC 1962
  • Country
  • SYRE United States
  • KFRC United States
  • Employees
  • SYRE N/A
  • KFRC N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • KFRC Professional Services
  • Sector
  • SYRE Health Care
  • KFRC Consumer Discretionary
  • Exchange
  • SYRE Nasdaq
  • KFRC Nasdaq
  • Market Cap
  • SYRE 841.4M
  • KFRC 811.3M
  • IPO Year
  • SYRE 2016
  • KFRC 1995
  • Fundamental
  • Price
  • SYRE $15.72
  • KFRC $43.33
  • Analyst Decision
  • SYRE Buy
  • KFRC Buy
  • Analyst Count
  • SYRE 6
  • KFRC 3
  • Target Price
  • SYRE $55.00
  • KFRC $53.67
  • AVG Volume (30 Days)
  • SYRE 673.0K
  • KFRC 140.3K
  • Earning Date
  • SYRE 08-06-2025
  • KFRC 07-28-2025
  • Dividend Yield
  • SYRE N/A
  • KFRC 3.55%
  • EPS Growth
  • SYRE N/A
  • KFRC N/A
  • EPS
  • SYRE N/A
  • KFRC 2.56
  • Revenue
  • SYRE N/A
  • KFRC $1,383,447,000.00
  • Revenue This Year
  • SYRE N/A
  • KFRC N/A
  • Revenue Next Year
  • SYRE N/A
  • KFRC $4.06
  • P/E Ratio
  • SYRE N/A
  • KFRC $17.21
  • Revenue Growth
  • SYRE N/A
  • KFRC N/A
  • 52 Week Low
  • SYRE $10.91
  • KFRC $35.50
  • 52 Week High
  • SYRE $40.26
  • KFRC $71.48
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 51.34
  • KFRC 56.59
  • Support Level
  • SYRE $14.97
  • KFRC $42.13
  • Resistance Level
  • SYRE $16.92
  • KFRC $45.14
  • Average True Range (ATR)
  • SYRE 1.12
  • KFRC 1.24
  • MACD
  • SYRE 0.02
  • KFRC 0.28
  • Stochastic Oscillator
  • SYRE 58.05
  • KFRC 66.26

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

Share on Social Networks: